Magellan Bioanalytics

Executive Summary

Magellan Bioanalytics is a San Diego-based biotechnology company that develops AI and machine learning software tools for mass spectrometry data analysis, with its flagship COMPASS software suite enabling comprehensive and rapid proteomics analysis. Founded in 2018, the company targets researchers in biotech, pharma, and healthcare, aiming to extract maximum insight from complex mass spec datasets. While the company operates in the growing proteomics and diagnostics space, it remains private with limited publicly available financial or operational details. Its AI-driven approach positions it well for increasing demand for advanced data analytics in precision medicine and biomarker discovery.

Upcoming Catalysts (preview)

• TBDCOMPASS Software Major Update Release60% success
• TBDStrategic Partnership with Pharma or Biotech40% success
• TBDSeries A or Series B Funding Round50% success